Opyl (ASX:OPL) - CEO, Michelle Gallaher
CEO, Michelle Gallaher
Sourced: Startup Daily
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Opyl (OPL) and the Association of Australian Medical Research Institutes have launched a social media guide to support medical researchers during COVID-19
  • Opyl has seen a 188 per cent increase in pandemic-related research findings being shared, as well as a 61 per cent increase in social media engagement since April
  • Opyl and AAMRI’s comprehensive guide will ensure that users are getting the right information from credible and knowledgeable sources
  • Company shares closed in the grey, trading for 7.3 cents each

Opyl (OPL) and the Association of Australian Medical Research Institutes (AAMRI) have launched a social media guide to support medical researchers during COVID-19.

Opyl is a social media technology company that specialises in the health and life-sciences industries.

Since the outbreak of COVID-19, Opyl has been monitoring online platforms. During this time, it has noted a 188 per cent increase in pandemic-related clinical and research findings being discussed and shared by medical researchers and healthcare professionals. Professionals in these fields have also been spending more time on social media sites than before.

According to Opyl, COVID-19 has seen a 61 per cent increase in social media engagement since the beginning of April.

“The need to disseminate trustworthy medical research, both quickly and broadly, has never been greater,” the company stated.

“It’s vital that Australian researchers know how to promote their research beyond the journals and ensure the new knowledge they’re creating gets noticed by a global audience. I hope our support helps Australian research go viral — for all the right reasons,” Opyl CEO Michelle Gallaher said.

Opyl and AAMRI’s comprehensive guide will ensure that users are getting the right information from credible and knowledgeable sources.

“For medical research institutes this is a real opportunity to share our knowledge and also demonstrate the huge amount of work we are undertaking for COVID-19 across Australia,” AAMRI President Professor Jonathan Carapetis AM said.

Company shares closed in the grey, trading for 7.3 cents each.

OPL by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…